Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Phase I/II Study of BNC105P in Combination With Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
Status: Enrolling
Updated:  5/16/2013
CTRC at The UT Health Science Center at San Antonio
mi
from
San Antonio, TX
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Phase I/II Study of BNC105P in Combination With Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
Status: Enrolling
Updated: 5/16/2013
CTRC at The UT Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Phase I/II Study of BNC105P in Combination With Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
Status: Enrolling
Updated:  5/16/2013
Lynchburg Hematology-Oncology Clinic
mi
from
Lynchburg, VA
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Phase I/II Study of BNC105P in Combination With Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
Status: Enrolling
Updated: 5/16/2013
Lynchburg Hematology-Oncology Clinic
mi
from
Lynchburg, VA
Click here to add this to my saved trials
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Phase I/II Study of BNC105P in Combination With Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
Status: Enrolling
Updated:  5/16/2013
Harrison HealthPartners Bremerton Hematology & Oncology
mi
from
Bremerton, WA
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Phase I/II Study of BNC105P in Combination With Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
Status: Enrolling
Updated: 5/16/2013
Harrison HealthPartners Bremerton Hematology & Oncology
mi
from
Bremerton, WA
Click here to add this to my saved trials
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Phase I/II Study of BNC105P in Combination With Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
Status: Enrolling
Updated:  5/16/2013
Cascade Cancer Center
mi
from
Kirkland, WA
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Phase I/II Study of BNC105P in Combination With Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
Status: Enrolling
Updated: 5/16/2013
Cascade Cancer Center
mi
from
Kirkland, WA
Click here to add this to my saved trials
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Phase I/II Study of BNC105P in Combination With Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
Status: Enrolling
Updated:  5/16/2013
Group Health Medical Centers
mi
from
Seattle, WA
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Phase I/II Study of BNC105P in Combination With Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
Status: Enrolling
Updated: 5/16/2013
Group Health Medical Centers
mi
from
Seattle, WA
Click here to add this to my saved trials
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Phase I/II Study of BNC105P in Combination With Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
Status: Enrolling
Updated:  5/16/2013
University of Washington/Seattle Cancer Care Alliance
mi
from
Seattle, WA
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Phase I/II Study of BNC105P in Combination With Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
Status: Enrolling
Updated: 5/16/2013
University of Washington/Seattle Cancer Care Alliance
mi
from
Seattle, WA
Click here to add this to my saved trials
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Phase I/II Study of BNC105P in Combination With Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
Status: Enrolling
Updated:  5/16/2013
Rockwood Clinic
mi
from
Spokane, WA
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Phase I/II Study of BNC105P in Combination With Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
Status: Enrolling
Updated: 5/16/2013
Rockwood Clinic
mi
from
Spokane, WA
Click here to add this to my saved trials
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Phase I/II Study of BNC105P in Combination With Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
Status: Enrolling
Updated:  5/16/2013
University of Wisconsin, Clinical Cancer Center
mi
from
Milwaukee, WI
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Phase I/II Study of BNC105P in Combination With Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
Status: Enrolling
Updated: 5/16/2013
University of Wisconsin, Clinical Cancer Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Examining a Common Complaint of Women Who Receive Chemotherapy for Breast Cancer- Cognitive Difficulty
Neurocognitive Impairment in Women With Early Stage Breast Cancer
Status: Enrolling
Updated:  5/16/2013
Virnigia Commonwealth University
mi
from
Richmond, VA
Examining a Common Complaint of Women Who Receive Chemotherapy for Breast Cancer- Cognitive Difficulty
Neurocognitive Impairment in Women With Early Stage Breast Cancer
Status: Enrolling
Updated: 5/16/2013
Virnigia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Statin Therapy Versus Placebo Prior to Prostatectomy
Pre-Operative Statin Therapy Versus Placebo in Human Prostate Cancer
Status: Enrolling
Updated:  5/20/2013
Durham VA Medical Center, Durham, NC
mi
from
Durham, NC
Statin Therapy Versus Placebo Prior to Prostatectomy
Pre-Operative Statin Therapy Versus Placebo in Human Prostate Cancer
Status: Enrolling
Updated: 5/20/2013
Durham VA Medical Center, Durham, NC
mi
from
Durham, NC
Click here to add this to my saved trials
Statin Therapy Versus Placebo Prior to Prostatectomy
Pre-Operative Statin Therapy Versus Placebo in Human Prostate Cancer
Status: Enrolling
Updated:  5/20/2013
VA Medical Center, Portland
mi
from
Portland, OR
Statin Therapy Versus Placebo Prior to Prostatectomy
Pre-Operative Statin Therapy Versus Placebo in Human Prostate Cancer
Status: Enrolling
Updated: 5/20/2013
VA Medical Center, Portland
mi
from
Portland, OR
Click here to add this to my saved trials
Role of Beta-Endorphin in Cancer Therapy Fatigue
Beta-Endorphin as a Mediator of Cancer Therapy-Induced Fatigue
Status: Enrolling
Updated:  5/21/2013
Massachusetts General Hospital
mi
from
Boston, MA
Role of Beta-Endorphin in Cancer Therapy Fatigue
Beta-Endorphin as a Mediator of Cancer Therapy-Induced Fatigue
Status: Enrolling
Updated: 5/21/2013
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Achieve Clinical Research
mi
from
Birmingham, AL
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Achieve Clinical Research
mi
from
Birmingham, AL
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Clinical Research Associates
mi
from
Huntsville, AL
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Clinical Research Associates
mi
from
Huntsville, AL
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Atlanta Gastroenterology
mi
from
Atlanta, GA
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Atlanta Gastroenterology
mi
from
Atlanta, GA
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Stroger Cook County
mi
from
Chicago, IL
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Stroger Cook County
mi
from
Chicago, IL
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Rush University Gastroenterologists
mi
from
Chicago, IL
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Rush University Gastroenterologists
mi
from
Chicago, IL
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Jesse Brown VA
mi
from
Chicago, IL
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Jesse Brown VA
mi
from
Chicago, IL
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
University of Illinois at Chicago
mi
from
Chicago, IL
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Rockford Gastroenterology Associates, Ltd.
mi
from
Rockford, IL
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Rockford Gastroenterology Associates, Ltd.
mi
from
Rockford, IL
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Gastroenterology Associates
mi
from
Baton Rouge, LA
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Gastroenterology Associates
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Commonwealth Clinical Studies
mi
from
Brockton, MA
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Commonwealth Clinical Studies
mi
from
Brockton, MA
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Long Island Gastrointestinal Group
mi
from
Great Neck, NY
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Long Island Gastrointestinal Group
mi
from
Great Neck, NY
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Mount Sinai School of Medicine
mi
from
New York, NY
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Asheville Gastroenterology
mi
from
Asheville, NC
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Asheville Gastroenterology
mi
from
Asheville, NC
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Southern Gastroenterology Associates
mi
from
New Bern, NC
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Southern Gastroenterology Associates
mi
from
New Bern, NC
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Northwest Gastroenterology Clinic, LLC
mi
from
Portland, OR
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Northwest Gastroenterology Clinic, LLC
mi
from
Portland, OR
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Gastro One
mi
from
Germantown, TN
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Gastro One
mi
from
Germantown, TN
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Digestive Health Specialists
mi
from
Tyler, TX
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Digestive Health Specialists
mi
from
Tyler, TX
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
University of Utah
mi
from
Salt Lake City, UT
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Digestive and Liver Disease Specialists
mi
from
Norfolk, VA
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Digestive and Liver Disease Specialists
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC)
A Single Arm, Phase 2 Study of Ganetespib in Subjects With Advanced Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Gene Rearrangement (ALK-Positive NSCLC)
Status: Enrolling
Updated:  5/22/2013
Synta Pharmaceuticals Investigative Site
mi
from
Tampa, FL
A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC)
A Single Arm, Phase 2 Study of Ganetespib in Subjects With Advanced Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Gene Rearrangement (ALK-Positive NSCLC)
Status: Enrolling
Updated: 5/22/2013
Synta Pharmaceuticals Investigative Site
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC)
A Single Arm, Phase 2 Study of Ganetespib in Subjects With Advanced Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Gene Rearrangement (ALK-Positive NSCLC)
Status: Enrolling
Updated:  5/22/2013
Synta Pharmaceuticals Investigative Site
mi
from
Detroit, MI
A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC)
A Single Arm, Phase 2 Study of Ganetespib in Subjects With Advanced Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Gene Rearrangement (ALK-Positive NSCLC)
Status: Enrolling
Updated: 5/22/2013
Synta Pharmaceuticals Investigative Site
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC)
A Single Arm, Phase 2 Study of Ganetespib in Subjects With Advanced Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Gene Rearrangement (ALK-Positive NSCLC)
Status: Enrolling
Updated:  5/22/2013
Synta Pharmaceuticals Investigative Site
mi
from
Cleveland, OH
A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC)
A Single Arm, Phase 2 Study of Ganetespib in Subjects With Advanced Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Gene Rearrangement (ALK-Positive NSCLC)
Status: Enrolling
Updated: 5/22/2013
Synta Pharmaceuticals Investigative Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Birmingham, AL
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Phoenix, AZ
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Santa Clara, CA
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Aurora, CO
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Decatur, GA
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Indianapolis, IN
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Boston, MA
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
St. Joseph, MO
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
St. Joseph, MO
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
New York, NY
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Cleveland, OH
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Portland, OR
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Philadelphia, PA
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Charleston, SC
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Chattanooga, TN
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials